Fondaparinux is a safe alternative in case of heparin intolerance during pregnancy |
| |
Authors: | Mazzolai Lucia Hohlfeld Patrick Spertini Francois Hayoz Daniel Schapira Marc Duchosal Michel A |
| |
Affiliation: | Service of Vascular Medicine, University Hospital of Lausanne (CHUV), Av Pierre Decker 5, 1011 Lausanne, Switerland. lucia.mazzolai@chuv.ch |
| |
Abstract: | Heparin is the drug of choice for the treatment or the prevention of thromboembolic disease during pregnancy. However, treatment options are limited when heparin cannot be used because of hypersensitivity skin reactions. Despite the recent availability of new anticoagulant agents, data relating to their use during pregnancy are lacking. This report describes the successful management with fondaparinux, during 150 days, of a pregnant patient with protein S deficiency and prior deep vein thrombosis (DVT) who developed heparin and danaparoid hypersensitivity. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
| 点击此处可从《Blood》浏览原始摘要信息 |
|
点击此处可从《Blood》下载免费的PDF全文 |
|